PHASE-II EVALUATION OF 4'EPI-DOXORUBICIN IN PATIENTS WITH METASTATIC COLORECTAL-CARCINOMA

被引：6

作者：

FERRAZZI, E ^{[1
]}

PAPPAGALLO, GL ^{[1
]}

NICOLETTO, O ^{[1
]}

FORNASIERO, A ^{[1
]}

REFATTI, F ^{[1
]}

CARTEI, G ^{[1
]}

VINANTE, O ^{[1
]}

FIORENTINO, MV ^{[1
]}

机构：

[1] OSPED CIVILE,DIV ONCOL MED,I-35100 PADOVA,ITALY

来源：

TUMORI | 1984年 / 70卷 / 03期

关键词：

D O I：

10.1177/030089168407000317

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：297 / 300

页数：4

共 17 条

[1] SYSTOLIC-TIME INTERVAL AS INDEX OF SCHEDULE - DEPENDENT DOXORUBICIN CARDIOTOXICITY IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA [J].

ALISMAIL, SAD ;

WHITTAKER, JA .

BRITISH MEDICAL JOURNAL, 1979, 1 (6175) :1392-1395

[2] SYNTHESIS AND ANTITUMOR PROPERTIES OF NEW GLYCOSIDES OF DAUNOMYCINONE AND ADRIAMYCINONE [J].

ARCAMONE, F ;

PENCO, S ;

VIGEVANI, A ;

REDAELLI, S ;

FRANCHI, G ;

DIMARCO, A ;

CASAZZA, AM ;

DASDIA, T ;

FORMELLI, F ;

NECCO, A ;

SORANZO, C .

JOURNAL OF MEDICINAL CHEMISTRY, 1975, 18 (07) :703-707

[3] TOXIC AND THERAPEUTIC ACTIVITY OF 4'-EPI-DOXORUBICIN [J].

BONFANTE, V ;

VILLANI, F ;

BONADONNA, G .

TUMORI JOURNAL, 1982, 68 (02) :105-111

[4]

CARTER SK, 1980, CANCER CHEMOTH PHARM, V4, P5

[5]

CASAZZA AM, 1978, CURRENT CHEMOTHERAPY, P1257

[6]

DAVIS HL, 1982, CANCER-AM CANCER SOC, V50, P2638

[7]

DELLACUNA GR, 1981, OCT UICC C CLIN ONC

[8] PHASE-II STUDY OF 4 EPI-DOXORUBICIN [J].

FERRAZZI, E ;

NICOLETTO, O ;

VINANTE, O ;

PAGNIN, P ;

MARAGLINO, G ;

GANZINA, F ;

FIORENTINO, MV .

TUMORI, 1982, 68 (05) :431-435

[9]

FRYTAK S, 1975, CANCER CHEMOTH REP 1, V59, P405

[10]

HALLER DG, 1978, CANCER TREAT REP, V62, P563

← 1 2 →